Literature DB >> 33531333

Covid-19: People who have had infection might only need one dose of mRNA vaccine.

Jacqui Wise1.   

Abstract

Entities:  

Year:  2021        PMID： 33531333     DOI： 10.1136/bmj.n308

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  21 in total

1.  First-dose mRNA vaccination is sufficient to reactivate immunological memory to SARS-CoV-2 in subjects who have recovered from COVID-19.

Authors:  Alessio Mazzoni; Nicoletta Di Lauria; Laura Maggi; Lorenzo Salvati; Anna Vanni; Manuela Capone; Giulia Lamacchia; Elisabetta Mantengoli; Michele Spinicci; Lorenzo Zammarchi; Seble Tekle Kiros; Arianna Rocca; Filippo Lagi; Maria Grazia Colao; Paola Parronchi; Cristina Scaletti; Lucia Turco; Francesco Liotta; Gian Maria Rossolini; Lorenzo Cosmi; Alessandro Bartoloni; Francesco Annunziato
Journal:  J Clin Invest       Date:  2021-06-15       Impact factor: 14.808

2.  Neutralizing antibodies levels are increased in individuals with heterologous vaccination and hybrid immunity with Ad5-nCoV in the north of Mexico.

Authors:  Karla Cervantes-Luevano; Astrid N Espino-Vazquez; Gonzalo Flores-Acosta; Johanna Bernaldez-Sarabia; Olivia Cabanillas-Bernal; Jahaziel Gasperin-Bulbarela; Ricardo Gonzalez-Sanchez; Andreu Comas-Garcia; Alexei F Licea-Navarro
Journal:  PLoS One       Date:  2022-06-24       Impact factor: 3.752

3.  Immunogenicity of mRNA-1273 COVID vaccine after 6 months surveillance in health care workers; a third dose is necessary.

Authors:  Marie Tré-Hardy; Roberto Cupaiolo; Alain Wilmet; Thomas Antoine-Moussiaux; Andrea Della Vecchia; Alexandra Horeanga; Emmanuelle Papleux; Marc Vekemans; Ingrid Beukinga; Laurent Blairon
Journal:  J Infect       Date:  2021-08-23       Impact factor: 38.637

4.  Analysis of continuous glucose tracking data in people with type 1 diabetes after COVID-19 vaccination reveals unexpected link between immune and metabolic response, augmented by adjunctive oral medication.

Authors:  Adrian H Heald; Rustam Rea; Linda Horne; Ann Metters; Tom Steele; Kathryn Leivesley; Martin Brunel Whyte; Mike Stedman; William Ollier
Journal:  Int J Clin Pract       Date:  2021-10-07       Impact factor: 3.149

5.  Safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2 : A phase 1 randomized clinical trial.

Authors:  Peter G Kremsner; Philipp Mann; Arne Kroidl; Isabel Leroux-Roels; Christoph Schindler; Julian J Gabor; Mirjam Schunk; Geert Leroux-Roels; Jacobus J Bosch; Rolf Fendel; Andrea Kreidenweiss; Thirumalaisamy P Velavan; Mariola Fotin-Mleczek; Stefan O Mueller; Gianluca Quintini; Oliver Schönborn-Kellenberger; Dominik Vahrenhorst; Thomas Verstraeten; Margarida Alves de Mesquita; Lisa Walz; Olaf-Oliver Wolz; Lidia Oostvogels
Journal:  Wien Klin Wochenschr       Date:  2021-08-10       Impact factor: 1.704

6.  SARS-CoV-2 mRNA vaccine induces robust specific and cross-reactive IgG and unequal neutralizing antibodies in naive and previously infected people.

Authors:  Tara M Narowski; Kristin Raphel; Lily E Adams; Jenny Huang; Nadja A Vielot; Ramesh Jadi; Aravinda M de Silva; Ralph S Baric; John E Lafleur; Lakshmanane Premkumar
Journal:  Cell Rep       Date:  2022-01-20       Impact factor: 9.995

7.  Population homogeneity for the antibody response to COVID-19 BNT162b2/Comirnaty vaccine is only reached after the second dose across all adult age ranges.

Authors:  João Faro-Viana; Marie-Louise Bergman; Lígia A Gonçalves; Nádia Duarte; Teresa P Coutinho; Patrícia C Borges; Christian Diwo; Rute Castro; Paula Matoso; Vanessa Malheiro; Ana Brennand; Lindsay Kosack; Onome Akpogheneta; João M Figueira; Conceição Cardoso; Ana M Casaca; Paula M Alves; Telmo Nunes; Carlos Penha-Gonçalves; Jocelyne Demengeot
Journal:  Nat Commun       Date:  2022-01-10       Impact factor: 14.919

8.  Diagnostic performance of two serological assays for the detection of SARS-CoV-2 specific antibodies: surveillance after vaccination.

Authors:  Alba Fresco-Taboada; Marga García-Durán; Cristina Aira; Lissett López; Patricia Sastre; Lia van der Hoek; Marit J van Gils; Philip J M Brouwer; Rogier W Sanders; Barbara Holzer; Irene Zimpernikc; Eduardo López-Collazo; Patricia Muñoz; Paloma Rueda; Carmen Vela
Journal:  Diagn Microbiol Infect Dis       Date:  2022-01-26       Impact factor: 2.983

9.  Side effects among healthcare workers from a large Milan university hospital after second dose of BNT162b2 mRNA COVID-19 vaccine.

Authors:  Elisa Borroni; Dario Consonni; Massimo Cugno; Andrea Lombardi; Davide Mangioni; Patrizia Bono; Massimo Oggioni; Sara Uceda Renteria; Lorenzo Bordini; Carlo Domenico Nava; Matteo Letzgus; Flaminia Gentiloni Silverj; Silvana Castaldi; Magda Rognoni; Luca Cavallieri D'Oro; Michele Carugno; Luciano Riboldi; Ferruccio Ceriotti; Alessandra Bandera; Andrea Gori; Angela Cecilia Pesatori
Journal:  Med Lav       Date:  2021-12-23       Impact factor: 1.275

10.  One year later: SARS-CoV-2 immune response and vaccination of healthcare workers post-infection.

Authors:  Chloé Dimeglio; Fabrice Herin; Marcel Miedougé; Isabelle Da-Silva; Marion Porcheron; Guillaume Martin-Blondel; Jean-Marc Soulat; Jacques Izopet
Journal:  J Infect       Date:  2021-06-18       Impact factor: 38.637
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.